Episode 37: ASCO GU 2026 Commentary: Kidney Cancer

from The View on GU | with Lalani and Wallis · host Dr. Aly-Khan Lalani & Dr. Christopher Wallis

Dr. Aly-Khan Lalani and Dr. Christopher Wallis also discuss the RAMPART trial, LITESPARK-011, and the K-COMPASS model. This final recap episode highlights how evolving adjuvant strategies and combination sequencing are reshaping the kidney cancer landscape. Be sure to listen to Episodes 35 and 36 for the full ASCO GU recap, covering key updates in prostate and bladder cancer!The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Pfizer, Tolmar, AbbVie, Astellas, Eisai, Ipsen, Merck, Bayer, TerSera.

Episode metadata supplied by the publisher feed · Published Mar 6, 2026

Embed this episode

Attribution link and audio player

Ready to play

Episode 37: ASCO GU 2026 Commentary: Kidney Cancer

0:00 30:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The View on GU | with Lalani and Wallis?

This episode is 30 minutes long.

When was this The View on GU | with Lalani and Wallis episode published?

This episode was published on March 6, 2026.

Can I download this The View on GU | with Lalani and Wallis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!